相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclosporine-loaded solid lipid nanoparticles (SLN®):: Drug-lipid physicochemical interactions and characterization of drug incorporation
R. H. Mueller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Oral bioavailability of cyclosporine:: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
R. H. Mueller et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC
E. B. Souto et al.
JOURNAL OF MICROENCAPSULATION (2006)
Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs
DM Shackleford et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs
SM Khoo et al.
PHARMACEUTICAL RESEARCH (2003)
Structured triglyceride vehicles for oral delivery of halofantrine:: Examination of intestinal lymphatic transport and bioavailability in conscious rats
R Holm et al.
PHARMACEUTICAL RESEARCH (2002)
Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate
C Olbrich et al.
JOURNAL OF DRUG TARGETING (2002)
Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) -: effect of surfactants, storage time and crystallinity
C Olbrich et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Intestinal lymphatic drug transport: an update
CJH Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Solid lipid nanoparticles -: Production, characterization and applications
W Mehnert et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems
CW Pouton
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment
SM Khoo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
RH Müller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
分享论文
